Biotech Chairman Yin Weidong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech chairman yin weidong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Chairman Yin Weidong Today - Breaking & Trending Today

China's Sinovac defends COVID-19 vaccine after disappointing Brazil data

China s Sinovac defends COVID-19 vaccine after disappointing Brazil data
FILE PHOTO: Media tour at Chinese vaccine maker Sinovac Biotech in Beijing
SHARE
China s Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.
The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on very mild cases, researchers said on Tuesday.
Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against mild-to-severe cases.
The news prompted Malaysia and Singapore, which have purchase agreements with Sinovac, to say on Wednesday that they would seek more data from the Chinese firm on efficacy rates before they approved and bought supplies. ....

Pharmaniaga Bhd , Sinovac Coronavac , Joko Widodo , Sinovac Biotech , Biotech Chairman Yin Weidong , President Joko Widodo , China 039 S , Covid 19 ,

UPDATE 2-China's Sinovac defends COVID-19 vaccine after disappointing Brazil data

Had reported 78% efficacy in mild-to-severe cases
Chairman says results are good around the world
Malaysia and Singapore seeking more data (Recasts to add details from Sinovac executive, Thailand and Singapore, and background)
KUALA LUMPUR/SINGAPORE, Jan 13 (Reuters) - China’s Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.
The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on “very mild” cases, researchers said on Tuesday.
Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against “mild-to-severe” cases. ....

Kuala Lumpur , Krung Thep Mahanakhon , Chen Lin , Jakarta Raya , Panarat Thepgumpanat , Stanley Widianto , Joseph Sipalan , Sinovac Coronavac , Ed Davies , Pharmaniaga Bhd , Mark Potter , Roxanne Liu , Chayut Setboonsarng , Joko Widodo , Sinovac Biotech , Biotech Chairman Yin Weidong , President Joko Widodo , Yew Lun Tian , Sayantani Ghosh Editing , Coronavirus Malaysia Update 2 , Asean Countries , Asia Pacific , Corporate Events , Biopharmaceuticals Trbc Level 5 , Company News , Communicable Diseases ,

Chinese COVID-19 vaccine downgraded from 78 to 50 per cent efficacy

Sinovac Biotech chairman says the results show their vaccine s safety and effectiveness are good around the world ....

Sinovac Coronavac , Joko Widodo , Sinovac Biotech , Biotech Chairman Yin Weidong , President Joko Widodo ,

Coronavirus: Philippines' Rodrigo Duterte defends purchase of Chinese COVID-19 vaccine

Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine after the Brazilian announcement that it was only 50.4% effective. ....

Sinovac Coronavac , Joko Widodo , Carlito Galvez , Sinovac Biotech , Russia Gamaleya Institute , World Health Organisation , Biotech Chairman Yin Weidong , President Joko Widodo , Gamaleya Institute , கார்லிட்டோ கால்வேஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

China's Sinovac defends COVID-19 vaccine after disappointing Brazil data

China's Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced. ....

Kuala Lumpur , Krung Thep Mahanakhon , Chen Lin , Jakarta Raya , Panarat Thepgumpanat , Stanley Widianto , Joseph Sipalan , Sinovac Coronavac , Ed Davies , Mark Potter , Pharmaniaga Bhd , Roxanne Liu , Chayut Setboonsarng , Sayantani Ghosh , Joko Widodo , Thomson Reuters Trust Principles , Sinovac Biotech , Biotech Chairman Yin Weidong , President Joko Widodo , Yew Lun Tian , Thomson Reuters Trust , Corona Virus , Asia Pacific , Biopharmaceuticals Trbc Level 5 , Company News , Communicable Diseases ,